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SUMMARY
Oral squamous cell carcinoma (OSCC) diagnoses in elderly patients are expected to double in the next 20 years. Current guidelines sug-
gest surgery as a preferred approach, but elderly patients are hardly considered suitable to challenging surgical treatments. Using a multi-
centric retrospective analysis, we evaluated the outcomes of 99 patients affected by OSCC and aged at least 70, who underwent to either 
transoral procedures (TP), open neck resection without (OR) or with reconstruction (ORR). In our cohort, overall survival was significantly 
hampered by concomitant diseases and postsurgical complications, whose development is driven by the former. Thus, our findings support 
the growing acceptance that chronological age alone should not be a sufficient contraindication for aggressive surgery in the treatment of 
OSCC. However, elderly patients affected by OSCC are undoubtedly delicate surgical candidates and accurate selection prior to surgery 
with curative intent is mandatory. 
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RIASSUNTO 
Nei prossimi vent’anni è previsto che il numero di diagnosi di carcinoma del cavo orale nel paziente anziano raddoppi. L’approccio chirur-
gico resta la terapia d’elezione sebbene sia dibattuto se esso possa essere praticabile negli anziani anche nei casi più demolitivi. Attraverso 
un’analisi retrospettiva multicentrica, abbiamo valutato 99 pazienti ultra-settantenni affetti da carcinoma della cavità orale sottoposti a 
chirurgia transorale, o resezione open con o senza ricostruzione. Nella nostra coorte, la sopravvivenza dei pazienti è stata negativamente 
influenzata dalla presenza di comorbidità e dallo sviluppo di complicanze post-operatorie. Inoltre, la comparsa di tali complicanze è 
stata posta in diretta correlazione con la presenza di una o più patologie concomitanti nel quadro clinico del paziente. Tuttavia, sebbene 
il paziente anziano sia un candidato delicato per approccio chirurgico ed un’accurata selezione sia quindi necessaria, i nostri risultati 
suggeriscono che l’età anagrafica non debba essere considerata una controindicazione sufficiente ad escludere a priori pazienti anziani 
candidati a trattamento chirurgico.
PAROLE CHIAVE: Cancro del cavo orale • Anziani • Chirurgia ricostruttiva • Complicanze • Lembi liberi • Qualità di vita
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Introduction
Alarming epidemiological data have been reported for 
many tumour histotypes, particularly for head and neck 
squamous cell carcinomas (HNSCC), including oral 
(OSCC). Indeed, an increase in diagnosis from the pre-
sent ~300,000 cases worldwide to ~500,000 is expected 
within 2035 (+65%). More worryingly, the ~115,000 
OSCC currently diagnosed in elderly patients (≥ 65 years 
old) are expected to double (about +104%) in the next 
20 years, while those in younger will “only” increase by 
about 40%  1. 
Current guidelines for treatment of OSCC require sur-
gery as the preferred approach, whereas they suggest ra-
diotherapy or chemoradiotherapy for advanced-stage can-
cer in the presence of adverse features 2. Photodynamic 
therapy may be otherwise considered as an approach for 
the management of previously-treated patients or for those 
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who are not suitable for conventional therapies. Therefore, 
complex reconstructive surgeries have been used more and 
more frequently in the last two decades to improve the post-
treatment quality of life. However, this trend determines an 
extension of surgical times, as well as a general need to 
carefully select patients, which is based on the most seri-
ous comorbidity to reduce complications and overall costs. 
In this scenario, elderly patients are not considered to be 
good candidates to undergo more challenging treatments, 
e.g. highly invasive resective/reconstructive surgery and 
complex chemotherapy schedule 3. 
To provide surgeons with a model to choose the most ap-
propriate treatment options, we retrospectively analysed 99 
patients aged at least 70, suffering for OSCC, and treated 
with radical intent with 3 different types of surgery: tran-
soral procedures (TP), open neck resection without recon-
struction (OR) and open neck resection with reconstruction 
(ORR). Major outcomes as well as the incidence of post-
treatment complications were evaluated, whereas predic-
tive factors involved in their occurrence were identified.
Materials and methods
Patients and surgery
After informed consent was obtained, all patients un-
derwent surgery for OSCC at the Policlinico Hospital in 
Modena or at the Martini - San Luigi Gonzaga Hospitals 
of Turin between January 1, 2001, and December 31, 
2012. Data collection from the medical charts included 
demographic information such as age and sex, TNM stag-
ing, tumour site and subsite, tumour histology, physical 
status according to the American Society of Anesthesi-
ologists (ASA) 4, age at the surgical time, type of surgery 
and neck dissection, type of reconstruction, duration of 
surgery, duration of hospitalisation (including days in in-
tensive care unit, ICU), comorbidities and perioperative 
complications. The assessed comorbidities were diabetes 
mellitus, hypertension, chronic obstructive pulmonary 
disease (COPD), cardiac diseases (including chronic heart 
failure, arrhythmia and coronary artery disease), hepatic, 
metabolic and cerebrovascular diseases.
In the present retrospective study, age at the time of sur-
gery ≥ 70 years 5-7, histological diagnosis of OSCC and 
surgical treatment with curative intent (as single modality 
or as part of a multimodality approach) were considered 
as inclusion criteria. 
The chart data of 99 patients were retrieved. The choice of 
the treatment was based on tumour stage and site, as well as 
comorbidities, but non-considering chronological age as a 
discriminatory factor. Procedures were classifiable as tran-
soral procedures (TP), meaning mini-microinvasive surgeries 
as well as the non-surgical photodynamic therapy, in 14 of 99 
patients (14.1%), open neck resection without reconstruction 
(OR) in 59 of 99 patients (59.6%) and open neck resection 
with reconstruction (ORR) in 26 of 99 patients (26.3%). 
Characteristics of the patient cohort are summarised in 
Table I, while stratification according to tumour site and 
sub-site is reported in Table II. 
Statistical analysis
The length of time from the date of diagnosis to the date 
of death (overall survival, OS) or to the date of death for 
disease (disease-specific survival, DSS) was estimated 
Table I. Characteristics of the 99 elderly patients undergoing head and 
neck surgery according to age, sex and pathological status.
  No. of patients 
(%)
Age, y 
Mean 77.0 ± 5.6
Range 70-93
70-79 70/99 (70.7%)
≥ 80 29/99 (29.3%)
Sex
Male 60/99 (60.6%)
Female 39/99 (39.4%)
Pathological 
status*
N0 N1 N2a N2b N2c N3
pT1 23 6 1 4 34/98 (34.7%)
pT2 24 4 1 3 1 1 34/98 (34.7%)
pT3 3 4 4 11/98 (11.2%)
pT4 10 2 1 6 19/98 (19.4%)
* We considered 98 patients because one patient was lacking pTNM.
Table II. Patient stratification accordingly to the lesion subsites.
  No. of patients (%)
Oral cavity 74/99 (74.7%)
Gingiva 9/74 (12.2%)
Lips 10/74 (13.5%)
Tongue 30/74 (40.5%)
Oral mucosa 16/74 (21.6%)
Hard palate 2/74 (2.7%)
Floor of the mouth 7/74 (9.5%)
Oropharynx 25/99 (25.3%)
Anterior wall 7/25 (28.0%)
Lateral wall 13/25 (52.0%)
Superior wall 5/25 (20.0%)
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using Kaplan-Meier curves. At the end of the study, the 
dates of last consultation for patients still alive were 
used for type-I censoring. Log-rank and Gehan-Breslow-
Wilcoxon tests (for early events) were used to compare 
Kaplan-Meier estimates between groups (number of co-
morbidities, tumour site, type of surgery and postopera-
tive complications). The CHAID (Chi-square Automatic 
Interaction Detection) method 8 was used to detect the op-
timal subdivision to maximise the differences in response 
within the different variables.
Univariate regression with colinearity analysis was used 
to evaluate independent risk factors (e.g. age at the sur-
gery ≥ 80 9, gender, presence of comorbidities, tumour 
stage, type of surgery and duration of surgery) for devel-
opment of perioperative and postoperative complications 
(within 30 days). Those significantly associated were in-
cluded in a multivariable logistic regression model.
Kaplan-Meier curves, log-rank and Gehan-Breslow-Wil-
coxon tests were performed with Graphpad Prism ver-
sion 6.0e (GraphPad Software, San Diego, CA, USA), 
whereas CHAID analysis, univariate regression with col-
inearity analysis and multivariate logistic regression were 
performed with IBM® SPSS® Statistics version 23 (IBM 
Corp., Armonk, NY, USA). All analyses were considered 
statistically significant at p < 0.05.
Results
Patient comorbidities
Concomitant diseases were present in 69 of 99 (69.7%) 
elderly patients, of whom 32 (32.3%) were affected by 
multiple (≥ 2) comorbidities. The most frequent were hy-
pertension (50.5%), cardiovascular disease (25.2%), dia-
betes mellitus (19.2%) and chronic obstructive pulmonary 
disease (COPD) (12.1%). The severity of each comorbid-
ity was scored and recorded according to the American 
Society of Anesthesiologists (ASA) physical status clas-
sification system 4 10 (Table III).
Surgery and postoperative morbidity
The mean surgical time was 3.4 ± 2.3 h, ranging from 0.5 
h to 10.5 h in patients aged 70-79 years and from 0.5 h to 
6.5 h in those ≥ 80 years (p = 0.156). 
Amongst treated patients, 31 (14 OR and 17 ORR) were 
postoperatively transferred to the intensive care unit 
(ICU) where they resided for an average time between 
1.6 days (70-79 years old) and 1.1 days (age ≥ 80 years; 
p  = 0.675). Transfer to the ICU was decided by the an-
esthesiologist and was based on duration of surgery, pre-
operative ASA score and complications occurred during 
surgery. Generally, the mean length of hospitalisation was 
21.0 days in 70-79 patients and 18.7 in those aged ≥ 80 
years (p = 0.537). Patients were discharged when com-
pletely cured and autonomous in major activities (swal-
lowing, breathing or cannula management).
Perioperative or postoperative complications affected 
30 of 99 patients (30.3%) of whom 21 of 70 (30.0%) in 
the age range 70-79 and 9 of 29 (31.0%) in ≥ 80 years 
(p = 0.890). 
Furthermore, stratifying patients for the type of surgery, no 
differences between groups were observed, although open 
techniques followed by reconstruction displayed a signifi-
cantly higher incidence of complications than with other 
techniques in patients 70-79 years old (p < 0.05, Fig. 1). 
In the 70-79 year group, 4 patients suffered systemic 
complications, 9 had local complications (mainly bleed-
ings, fistulas and wound infections) and 5 developed both 
systemic and local complications. One patient suffered of 
multiple systemic complications, whereas 1 patient had 
2 local complications. Two patients (9.5%) died postop-
eratively. In the elderly aged ≥ 80, 4 patients developed a 
systemic complication, 1 patient had 2 systemic compli-
cations, whereas 4 patients suffered of local complication. 
One patient (11.1%) died postoperatively (Table IV). Fi-
Table III. Distribution of patients according to the American Society of An-
esthesiologists (ASA) physical status classification system.
  No. of patients (%)
ASA 
1 9/97 (9.3%)
2 34/97 (35.1%)
3 43/97 (44.3%)
4 10/97 (10.3%)
5 1/97 (1.0%)
Fig. 1. Incidence of complications on patients treated by transoral proce-
dure (TP), open neck resection (OR), or open neck resection with reconstruc-
tion (ORR). * = p < 0.05.
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nally, 27 of 99 patients (27.3%) underwent a second surgi-
cal procedure, whereas 9 of 99 patients (9.1%) underwent 
a third salvage surgery.
Correlation of age, comorbidities, tumour site, type of 
surgery and complications with patient survival
Patients were followed for a mean period of 2.52 years 
(range 6 days – 9.3 years). At the last follow-up, 40 of 99 
patients (40.4%) were alive without disease, 26 died with 
disease (26.3%) and 24 died for other reasons than head 
and neck cancer (24.2%), whereas 8 were alive with disease 
(8.1%). The remaining patient was lost to follow-up (1.0%). 
At 5 years, overall survival (OS, 41.1%) was not signifi-
cantly affected by patient age at the surgery. In fact, OS 
was 49.9% in those 70-79 years old and 18.4% in those 
aged ≥ 80 years (p = 0.176; for early events p = 0.433), 
with 50% mortality at 3.6 and 1.7 years, respectively (Fig. 
2A). Likewise, 5-year disease-specific survival (DSS, 
66.1%) was 64.4% in 70-79 year old patients and 71.6% 
in the older ones (Fig. 2B; p = 0.677).
Furthermore, by stratifying chart data, we found that the 
presence of ≥  2 comorbidities at diagnosis significantly 
worsened life expectancy of patients (p < 0.05). In these 
cases, OS was 23.9% (50% mortality at 1.5 years), whereas 
it was 53.4% and 48.2% (50% mortality at 3.9 years), re-
spectively, in patients without or with 1 comorbidity (Fig. 
3a). Otherwise, the anatomical localisation of the pathol-
ogy had a marginal role (p = 0.510, Fig. 3b): patients with 
tumours in the oral cavity had 45.5% OS (50% mortality at 
3.6 years), whereas those in which the pathology involved 
the oropharynx had 35.9% (50% mortality at 2.4 years).
Regarding treatment, OS was affected by the presence of 
post-operative complications, although the choice of sur-
gical technique did not play a direct role. In fact, 5-year 
OS of patients who experienced perioperative and post-
operative complications was 31.2% (50% mortality at 1.4 
years), which is significantly lower (p < 0.05; for early 
events p < 0.01) compared to 46.1% (50% mortality at 4.5 
years) of the other patients (Fig. 3c). Otherwise, patients 
treated by a more invasive ORR had 5-year OS of 41.0% 
vs. 42.3% and 52.4% of those treated by OR and TP, re-
spectively (p = 0.754) (Fig. 3d).
Risk analysis on the development of complications
Even if no variables evaluated displayed colinearity, age ≥ 
80 years, gender, previous treatments, ASA physical status 
classification and duration of surgery did not show statis-
tically significant correlations at univariate regression with 
the onset of perioperative and postoperative complications. 
On the contrary, they were correlated with the presence of 
concomitant diseases, tumour stage and type of surgery. 
Fig. 2. Overall survival (A) and disease-specific survival (B) over a 5-year 
period in 99 patients with oral squamous cell carcinoma. 
Table IV. Complications in patients.
Complications Number of events (%)
70-79 ≥ 80
Local Fistula 3/21 (14.3%) 1/9 (11.1%)
Infections 5/21 (23.8%) 0/9 (0.0%)
Haemorrhage 2/21 (9.5%) 1/9 (11.1%)
Haematoma 0/21 (0.0%) 0/9 (0.0%)
Necrosis 1/21 (4.8%) 1/9 (11.1%)
Dehiscence 3/21 (14.3%) 1/9 (11.1%)
Wound diastasis 0/21 (0.0%) 1/9 (11.1%)
Seroma 3/21 (14.3%) 0/9 (0.0%)
Systemic Pneumonia 2/21 (9.5%)  2/9 (22.2%)
Cardiovascular* 6/21 (28.6%)  1/9 (11.1%)
Psychiatric 3/21 (14.3%)  1/9 (11.1%)
Death 2/21 (9.5%)  1/9 (11.1%)
Nephropathy 0/21 (5.6%) 0/9 (0.0%)
Cerebrovascular event 1/21 (4.8%) 0/9 (0.0%)
Hyperglycaemia 1/21 (4.8%) 1/9 (11.1%)
Sepsis 0/21 (0.0%) 0/9 (0.0%)
* Cardiovascular complications included acute miocardial infarction, arrhythmia, and 
cardiac arrest.
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In fact, patients affected by ≥ 2 comorbidities were 
prone to develop complications with a risk of 53.1%, 
which is significantly higher than those with 1 con-
comitant disease (27.1%, p < 0.05) or without any co-
morbidities (10%, p < 0.001). Similarly, patients who 
were diagnosed with early stage tumours had a lower 
risk (13.0% stage I and 16.7% stage II) to incur compli-
cations than those with advanced-stage disease (43.8% 
stage III and 45.7% stage IV, p < 0.01). Finally, patients 
undergoing ORR had an higher risk (p < 0.05) of devel-
oping complications (50.0%) compared to those treated 
by OR (23.7%) or TP (21.4%). 
Concomitant diseases, tumour stage and type of surgery 
were included together with the non-statistically signifi-
cant age parameter in the following multivariate logistic 
regression model (p < 0.001, Likelihood Ratio L test):
where: (a) = patient aged 70-79; (b) = treatment by 
OR; (c) = treatment by ORR; (d) = absence of comor-
bidities; (e) = presence of 1 comorbidity; (f) = stage-I 
neoplasm; (g) = stage-II neoplasm; (h) stage-III neo-
plasm. 
In the regression model (Table V), the type of surgery was 
not statistically significant for the predisposition to devel-
op complications (p = 0.170). Their rate was determined 
accordingly, stratified for both concomitant diseases and 
pathology stage, and reported in Table VI.
Discussion
Worldwide, the progressively aging population makes 
treatment of elderly patients more frequent than in the past. 
Nevertheless, the elderly have the tendency to be often 
considered as a population that should be treated by less 
invasive/time-consuming procedures. Furthermore, full 
scientific agreement about not considering age by itself as 
a risk factor for incidence of surgical complications in the 
elderly it is still lacking 11-18. Consequently, aggressive sur-
gery on older patients has been generally infrequent until 
now 19 . However, it has been recently demonstrated for the 
treatment of laryngeal cancer that the employment of more 
invasive surgical procedures can also be adequate to treat 
older patients, albeit with some recommendations 20.
Fig. 3. Overall survival over a 5-year period of patients stratified for: presence of comorbidities at the diagnosis (A), tumour site (B), experience of peri- and/
or post-operative complications (C), or employed surgical procedure (D). * p < 0.05 (Log-Rank test); # p < 0.05, ### p < 0.001 (Gehan-Breslow-Wilcoxon 
test for early events). TP, transoral procedure; OR, open neck resection; ORR, open neck resection with reconstruction.
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This finding could also be relevant for oral cancer. In the 
elderly, indeed, it is almost always (95%) diagnosed as 
squamous cell carcinoma (OSCC) 21  22, a tumour histotype 
characterised by an intrinsic resistance to non-surgical ap-
proaches like radiotherapy and chemotherapy (including 
the newest proton therapy and “target therapy”) 23-25. The 
clinical evolution of OSCC has led to a rapid and strong 
decline in both life quality and expectancy, and includes 
pain, dysphagia, odynophagia, bleeding, fetor ex ore, 
teeth loss, inability to swallow and tumour externalisation 
from mouth and facial skin with consequent irreparable, 
permanent socially disfiguring impairment. The function-
al, cosmetic and psychological repercussions suffered by 
OSCC patients frequently result in significant burden for 
them, their families and society. Generally, their nutrition-
al status is poor and depression is frequent, with important 
somatic problems that often cause social isolation. 
In this context, surgery can be considered the only reliable 
approach and is, hence, the treatment of choice for all tu-
mour stages 2. Thus, the exclusion criteria of patients with 
diagnosis of OSCC from surgery (including more invasive 
techniques) should be finely defined, avoiding the a priori 
exclusion of older patients to more challenging therapeu-
tic options because wrongly considered as frail 10 19.
In this retrospective study, we considered a cohort of old 
(70-79 years) and very old (≥ 80 years) patients 9 affected 
by OSCC, in order to understand whether age represents 
per se a contraindication to treatment with open invasive 
surgery. Both old and very old populations were treated 
by one of three different approaches (transoral proce-
dures, TP, open neck resection, OR, and open neck re-
section with reconstruction, ORR), chosen according to 
tumour stage and site, as well as comorbidities. The dis-
tribution of patients to surgical techniques was homoge-
neous between the two groups. Likewise, no differences 
were detected among groups after comparison between 
surgical time, number of ICU and hospitalisation days 
and incidence of complications. No significant differ-
ences were detected in terms of overall survival (OS) at 5 
years from surgery, though a poorer 18.4% was detected 
in ≥ 80 year old patients vs 49.9% of those 70-79 years 
(p = 0.176). This non-significant difference was likely due 
to physiological instead of pathological causes, since dur-
ing the same period disease-specific survival (DSS) was 
at some extent better (71.6%) in ≥ 80 years than in those 
70-79 (64.4%, p = 0.677) years. This finding is further 
corroborated if we consider younger cohorts. In fact, fol-
lowing 489 patients (median age = 62) affected by oral tu-
mours (40% in advanced stage), Rogers and co-workers 26 
achieved 74% DSS after 5 years from surgical treatment. 
Furthermore, they reviewed the results from other cohorts 
in which the 5-year DSS varied from 49% to 84%. Com-
bining the data, we can deduce an overall cohort of 805 
patients with a DSS of 73.4% that is completely super-
imposable (p = 0.871) with our full-cohort DSS (66.1%).
By patient stratification, we detected that OS was affected 
by both comorbidities at diagnosis and post-operative 
complications. Patients with ≥ 2 comorbidities had 23.9% 
OS vs. ~50% seen in the others. Similarly, patients who 
developed complications had 31.2% OS compared to 
the 46.1% of those who did not (p < 0.05), although the 
phenomenon was more evident in the first post-operative 
years (p < 0.001). Otherwise, tumour localisation as well 
as the choice of surgical approach did not have an appar-
ent role in OS, even if we detected a higher incidence of 
complications (p < 0.05) in those 70-79 years undergo-
ing a more extended ORR approach. As recently stated by 
Grammatica and coworkers, reconstruction still remains 
a complex procedure that affects the development of both 
local and systemic perioperative complications 27.
As a confirmatory result, at univariate analysis the fac-
tors involved in the development of complications for our 
patient cohort were the presence of comorbidities, tumour 
stage and type of surgery employed, rapidly discharging 
any implication role of age, gender, previous treatments, 
ASA score and duration of surgical treatment. Neverthe-
less, at multivariate analysis, the role of each surgical 
approach became statistically negligible, highlighting a 
predominant involvement of tumour stage and above all 
the presence of concomitant diseases. Patients without 
comorbidities had a small to moderate risk in develop-
ing post-operative complications, even facing more ad-
Table V. Multivariate regression analyses for the development of post-op-
erative complications.
-2 Log 
(Λ)
χ2 df P
Advanced stage 67.085 9.684 3 0.021
Comorbidities 73.974 16.572 2 0.000
Invasive surgical techniques 60.948 3.547 2 0.170
Age ≥ 80 57.942 0.541 1 0.462
Λ, likelihood ratio; χ2, chi squared; df, degrees of freedom.
Table VI. Complication risks (%).
No. of comorbidities
0 1 ≥ 2
Tumour stage I 1.8 – 5.4  5.9 – 11.4 17.4 – 50.3
II 2.1 – 9.4  6.8 – 25.9 27.9 – 44.9
III 9.6 18.6 – 52.3 55.0 – 85.5
IV  8.5 – 30.9 23.8 – 60.0 62.5 – 88.9
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vanced pathologies (stage III/IV, 8.5-30.9% risk). At any 
rate, the risk is already increased for patients facing very 
early stage tumours, but with ≥ 2 concomitant diseases (I/
II, 17.4-50.3% risk).
As final digression, we would conclude that no differences in 
terms of functional outcomes (oral diet, speech intelligibil-
ity, and mouth opening) were detected among old and very 
old patients. Even if in our cohort much chart data did not 
report functional outcomes and for this reason results can 
only be considered as preliminary, they seem to be in ac-
cordance with the results of Nao and co-workers 28, although 
they compared younger patients (< 70 vs ≥ 70 years).
Conclusions
Up to now, it is widely accepted that elderly OSCC patients 
could not be treated with the standard of care because of 
medical prejudices related to advanced age. Nevertheless, 
our findings support the growing acceptance that chrono-
logical age alone should not be a sufficient contraindica-
tion for aggressive surgical therapy for OSCC. Instead, 
the presence of comorbidities at diagnosis might play a 
pivotal role in the choice of the more appropriate treat-
ment of elderly patients. In multivariate analysis, indeed, 
comorbidities correlated with the development of post-
surgical complications, thus foreclosing access to many 
treatment options. For these reasons, elderly patients af-
fected by OSCC are undoubtedly delicate surgical candi-
dates and accurate selection based on our results prior to 
surgery for curative intentions is mandatory.
Sharing and improving our knowledge in elderly patients 
is helpful for all clinicians due to aging of the population, 
with the aim to improve the quality of life and overall sur-
vival in elderly patients. 
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